90results about How to "Meet urgent clinical needs" patented technology

The present invention discloses a medicine for curing chronic pharyngitis and the preparation method; the present invention belongs to an improved dose type of pharyngitis tablet. The medicine for curing chronic pharygitis comprises tablets made of the raw materials of medicinal ingredient tablets with corresponding weigh portions which are wrapped by film coating made of film coating materials: 120 portion of figwort roots, 150 portion of dyers woad roots, 90 portion of asparagus roots, 90 portion of winter wheat, 90 portion of moutan bark, 90 portion of stemona roots, 90 portion of Chinese white olive, 90 portion of coltsfoot flowers, 90 portion of rehmannia roots, 30 portion of Indian trumpet flowers, 30 portion of cicada slough and 0.3 portion of mint oil. In this way, the sugar coat can be prevented from changing color and being made tainted caused by the nature of cane sugar that attracting dampness and the product stability is increased and the application population is enlarged. The new process is stable and simple and the quality can be controlled; the repeatability is good and the present invention is fit for large-scale production.

The present invention belongs to the field of medicine technology, and is especially one kind of medicine composition for treating liver diseases and its preparation process. The medicine composition is prepared with wolfberry fruit 50- 1000 weight portions, angelica 50-1000 weight portions, and glycyrrhizic acid or its pharmaceutically acceptable salt 1-50 weight portions; or with wolfberry fruit polysaccharide 2.5-50 weight portions, angelica polysaccharide 1-20 weight portions, and glycyrrhizic acid or its pharmaceutically acceptable salt 1-50 weight portions. It may be prepared into any pharmaceutically acceptable forms, preferably orally taken preparation and injection. It is used mainly for treating various liver diseases, including viral hepatitis, medicinal liver injury, fatty liver, alcohol liver, etc.

Disclosed is a novel pharmaceutical composition for treating liver diseases and process for preparation, wherein the pharmaceutical composition mainly comprises glycyrrhizic acid or its pharmaceutically acceptable salts, tiopronin, kurarinone, one or more of silybin or its derivatives or silymarin, rhodiola rosea or rhodiola rosea, the composition can be prepared into any one of the pharmaceutically acceptable dosage forms, preferably injections and oral preparations.

The present invention discloses a medicine composition, its preparation method and preparation containing said medicine composition. Said medicine composition includes (b y weight portion) 500-8000 portions of astragalus root, 50-2000 portions of ganoderma and 0.4-100 portions of glycyrrhizinic acid or its pharmaceutical acceptable salt. Besides, said medicine composition also can be made up by using (by weight portion) 5-120 portions of astragalus polysaccharide, 1-32 portions of ganoderma polysaccharide and 0.4-100 portions of glycyrrhizinic acid or its pharmaceutical acceptable salt. Said medicine composition can be used for preparing the medicines capable of curing the diseases of hepatitis B, chronic hepatitis, active hepatocirrhosis and hepatic fibrosis, etc.

The present invention belongs to the field of medicine technology, and is especially one medicine composition for treating hepatitis and its preparation process and use. The medicine composition consists of glycyrrhizic acid or its pharmaceutically acceptable salt 4-800 weight portions, ginseng 250-16000 weight portions, and glossy ganoderma 500- 20000 weight portions. It may consist of glycyrrhizic acid or its pharmaceutically acceptable salt, the extract of ginseng and the extract of glossy ganoderma. It may be prepared into different forms. The medicine composition has the synergistic effect of the components, high stability, high effect and wide application.

The present invention belongs to the field of medicine technology, and is especially one kind of medicine composition for treating cardiac and cerebral vascular diseases and its preparation process. The medicine composition is prepared with red sage in 100-1000 weight portions and rhodiola root in 25-300 weight portions, and may be also prepared with red sage extract and rhodiola root extract in the weight ratio of 1 to 0.01-20. The medicine composition may be prepared into different pharmaceutically acceptable forms, such as injection and orally taken preparation. The medicine composition has synergistic pharmaceutical effects of antagonizing platelet aggregation, resisting thrombosis, improving myocardial blood supply, etc and may be used in treating coronary heart disease, myocardial infarction, ischemic cerebral vascular diseases, etc.

The invention belongs to the field of pharmacy, and discloses a pharmaceutical composition mainly used for antineoplastic actions, the process for preparation and use thereof, wherein the composition comprises (by weight ratio) barbat skullcap 200-4000 parts, radical lobelia 200-4000 parts or corresponding weight parts of extract. The composition can also include 100-2400 parts of flavescent sophora root extract and can be prepared into any of the pharmacologically acceptable dose forms.

A composite medicine for preventing and treating tumor is proportionally prepared from oldenlandia or its extract, ginseng or its extract, and astragalus root or its extract. Its preparing process is also disclosed.

The present invention belong to the field of Chinese medicine technology, in the concrete, it discloses a Chinese medicine for effectively curing cardio-cerebral vascular diseases, its preparation method and application. Said Chinese medicine is made up by using 9 Chinese medicinal materials of rhodiola root, schisandra berry, Chinese angelica root, biota seed, spiny jujube kernel and others through a certain preparation process. Said Chinese medicine can be used for mainly curing the diseases of angina pectoris, hypertension, hyperlipemia and arteriosclerosis, etc. Besides, said invention also provides the concrete steps of its preparation process.

The invention belongs to the medical technical field and discloses a drug combination used for the cardio-cerebrovascular disease. The drug combination contains the pharmacodynamic components of the raw materials of the drugs of snakegourd or snakegourd extract and hawthorn leaves or hawthorn leaf extract. The invention also discloses preparations, which contain the drug combination and the preparation method of the preparations. The drug combination can be made into the preparation type, which is acceptable in the clinic or the pharmacy, and the injection preparation and the oral preparation are preferential. The drug combination is mainly used for remedying the cardio-cerebrovascular diseases of the coronary heart disease, the angina, the miocardial infarction, the blood stasis type corpulmonale, the ischemic encephalopathy, the cerebral thrombosis, the hypertension, the hyperlipemia etc. The drug combination of the invention has the synergistic interaction. Compared with simply using the snakegourd or the snakegourd extract and the hawthorn leaves or the hawthorn leaf extract, the effect is improved greatly, and the invention is provided with low toxicity, high safety and good stability.

The invention relates to a Chinese medicine composition for treating sepsis and a preparation method thereof. The Chinese medicine composition comprises active ingredients prepared from the following traditional Chinese medicines in parts by weight: 10-20 parts of radix bupleuri, 10-20 parts of radix scutellariae, 10-20 parts of radix salviae miltiorrhizae, 1-5 parts of Chinese rhubarb, 5-10 parts of coptis chinensis, 8-10 parts of radix paeoniae rubra, 5-10 parts of ginseng, 8-10 parts of root of rehmannia, 10-20 parts of honeysuckle, 5-10 parts of fruit of trifoliate orange and 5-10 parts of liquorice. According to the Chinese medicine composition disclosed by the invention, fungi, toxicity and inflammation are treated simultaneously by utilizing synergistic effect of various ingredients, various ways and various target points of the traditional Chinese medicines; in addition, the Chinese medicine composition has unique and exact effects of controlling sepsis in early stage and turning and cutting off the disease development, and has excellent remote effects.

The present invention belongs to the field of medicine technology and discloses an effective dose containing acetylcysteine or pharmaceutically acceptable salts thereof, and at least one pharmaceutical composition of anti-infective drugs as well as usage and method for making same, wherein the antiinfective drugs are one or several compounds selected from new houttuynine sodium bisulfite or pharmaceutically acceptable salt thereof and / or 14-dehydroxyl-11, 12-dehydro andrographolide-3, 19-di-succinic acid half-ester salts and / or matrine. Said pharmaceutical composition can be made into pharmaceutically acceptable dosage forms and exhibits cooperative building action when being used for diseases such as pneumonia, bronchial asthma, haggis acute inflammation accompanying with chronic emphraxis haggis diseases caused by sensitive bacteria; in addition, possesses excellent stability, exhibits considerably improved effects relative to used individually medicament of the same dose, and results in effects beyond thoughts, possesses wide-ranging applications foreground.

The invention discloses an antineoplastic medicinal composition containing at least ginseng or its extract, ophiopogon root or its extract, schisandra fruit or its extract, the process for preparation and use thereof, wherein the medicament is one or two selected from cantharidin or derivatives or analogues, and toad venoms. The composition can be used for treating hepatic carcinoma, esophagus cancer, cardiac cancer, lung carcinoma, breast cancer, intestinal cancer, malignant lymphoma, hepatitis and cirrhosis.

In order to meet the clinical needs, better treat cardiovascular and cerebrovascular diseases and improve the health level of the people, the invention provides a new pharmaceutical composition for the treatment of the cardiovascular and cerebrovascular diseases and its preparation method, and the pharmaceutical composition is mainly prepared from hawthorn leaves, allium macrostemon, polygonatum and rhizoma polygonati, and produces previously unimagined effects on the treatment of the cardiovascular and cerebrovascular diseases.

The invention discloses a pharmaceutical composition against hepatitis, its preparing process and use, wherein the composition comprises (by weight ratio) silybin or its derivatives 25-400 parts, radix isatidis 200-20000 parts, or silybin or its derivatives 25-400 parts, radix isatidis extract 1-400 parts. The composition can be prepared into clinically and pharmaceutically acceptable dosage forms having synergic action against hepatitis.

The invention discloses a pharmaceutical composition for treating cardiovascular and cerebrovascular diseases, its preparation process and use, wherein the composition is prepared mainly from ginseng, pseudo-ginseng, pericarpium trichosanthis and ginkgo leaf. The composition can be made into any clinically and pharmaceutically acceptable dose forms, preferably oral preparations.

A medical composition used to prepare the medicines for treating pneumonia, bronchial asthma, chronic obstructive pneumonia, and acute inflammation of lung is composed of acetylcysteine or its pharmacologically acceptable salt (20-1200 Wt. portions) and asarone (1-200). Its preparing process is also disclosed.

The present invention discloses a new medicine composition and its preparation method. Said medicine composition is formed from (by weight portion) 100-1600 portions of kurarinone, 500-24000 portions of ganoderma and 1000-80000 portions of astragalus root. Besides, it also can be made up by using 100-1600 portions of kurarinone, 2.5-700 portions of ganoderma polysaccharide and 5-1600 portions of astragalus polysaccharide. Said medicine composition can be made into various dosage forms, can be used for preparing the medicines capable or curing acute and chronic hepatitides and active hepatocirrhosis, etc.

The present invention belongs to the field of medicine technology, and is especially one medicine composition for treating hepatitis and its preparation process and use. The medicine composition consists of glycyrrhizic acid or its pharmaceutically acceptable salt 4-800 weight portions, ginseng 250-16000 weight portions, and astragalus root 5000- 80000 weight portions. It may consist of glycyrrhizic acid or its pharmaceutically acceptable salt, the extract of ginseng and the extract of astragalus root. It may be prepared into different forms. The medicine composition has the synergistic effect of the components, high stability, high effect and wide application.

A Chinese medicine for treating cardiovascular and cerebrovascular diseases, such as cerebral thrombosis, coronary heart disease, angina pectoris, vasculitis, myocardiac infarction and hyperlipemia, is prepared from safflower and hawthorn leaf, or their extracts (safflower yellow and hawthorn leaf flavone).

The present invention belongs to the field of medicine technology, and discloses one kind of mechanical composition, which consists of kurarione, glossy ganoderma or glossy ganoderma polysaccharide, and lentinan. It is used in treating liver cancer, lung cancer, osophagus cancer, hepatitis, etc and may be also used in the operational treatment, radiotherapy and chemotherapy of cancer. It has synergistic effect of the components, may be prepared into different forms and possesses wide application foreground.

The invention discloses a medicament for treating malignant tumors, and relates to the technical field of traditional Chinese medicines. The medicament is prepared by processing oldenlandia diffusa, sculellaria barbata, poria cocos, fructus arctii, achyranthes and atorvastatin calcium as raw materials according to the requirements of compatibility, and the medicament is preferably prepared into capsules and tablets. The pharmaceutical composition has certain symptom relieving, tumor shrinkage and tumor growth inhibition effects and the like on various malignant tumors such as lung cancers, liver cancers, gastric cancers, colorectal cancers, breast cancers, brain tumors and lymph cancers, can enhance the human immunity and prolong the lives of patients with tumors, and can effectively relieve adverse reactions such as leukopenia, dizziness, tireness, power leakage, emaciation, poor stomach intake and nausea and vomiting caused by the radiotherapy and chemotherapy of tumors.

The invention is concerned with the method of preparation of the compound medicine for anti-tumor, and it contents: ginseng, Tuckahoe, radix sophorae flavescentis and / or oldenlandia diffusa; or ginsenoside, Tuckahoe polysaccharide, radix sophorae flavescentis with total alkali and / or oldenlandia diffusa extract to make the kind of potion is acceptable for phamarcy.

The invention relates to a method for preparing new compound drug, wherein it mainly comprises Cordyceps sinensis mycelium at 50-2000 deals or its extractive at 0.2-40 deals, and 10-500 deals of kuh-seng, while it also can contain 10-5000 deals of milk vetch root or the milk vetch root polysaccharide extractive at 0.1-100 deals, or the milk vetch root saponin at 0.1-100 deals. The invention can be made into oral or injection agent, with anti-cancer, antibiosis funtoins, etc.

An anti-infective and antiviral medicinal composition for antipyresis and analgesia is proportionally prepared from 14-dehydroxy-11,12-didehydro andrographolide-3,19- semi-ester succinate and honeysuckle flower or its extract. Its preparing process is also disclosed.

The invention belongs to the technical field of medicine, and discloses a medicine for angina pectoris and a preparation method thereof. The medicine is mainly prepared from the trichosanthes quince, safflower and gardenia according to a certain weight ratio. It can be made into any clinically or pharmaceutically acceptable dosage form, preferably an oral preparation. The drug has the effects of regulating qi and broadening the chest, promoting blood circulation and relieving pain. It can be used for angina pectoris, symptoms include chest pain, frequent colic, fixed pain, or chest fullness such as pressure.

An anticancer medical composition for treating cancers, leukemia, hepatitis, hepatocirrhosis, etc is proportionally prepared from gynostemma pentaphyllum or its extract, cordyceps or its extract, cantharidin or its derivative or its analog, and / or toad venom or its extract. It can be used the relative medicine by mixing it with the pharmacologically acceptable auxiliaries.

The invention relates to a traditional Chinese medicine composition for treating cough and a preparation method thereof. The traditional Chinese medicine solves the problem that the existing western medicine for treating cough has side effects, causes medicine dependence and resistance easily and can only treat external symptoms but root causes. The traditional Chinese medicine composition comprises 70-230 parts by weight of folium rhododendri daurici extract, 200-600 parts by weight of bitter apricot kernel extract and 100-400 parts by weight of Zhejiang fritillaria bulb extract. The preparation method comprises the following steps of 1, folium rhododendri daurici extract preparation, 2, bitter apricot kernel extract preparation, 3, Zhejiang fritillaria bulb extract preparation and 4, mixing and accessory material addition. Compared with a single medicine, the traditional Chinese medicine composition has obvious effects, acts on peripheral nervous endings, does not influence nervous centralis, is safe, has no side effects, avoids medicine dependence and resistance and realizes treatment on both external symptoms and root causes. The traditional Chinese medicine composition is used for cough treatment.

The invention discloses an antineoplastic pharmaceutical composition, its preparing process and use, wherein the composition comprises the following raw materials (by weight portion), ginseng 200-20000 parts, astragalus root 200-40000 parts, coix seed oil 4000-100000 parts and / or cantharidin or derivative or analogues 0.02-5000 parts. The composition can also be prepared from ginseng extract, astragalus root extract, coix seed and / or cantharidin or derivative or analogues, and can be prepared into clinically and pharmaceutically acceptable dosage forms.